Efficacy of granisetron in the prevention of nausea and vomiting among paediatric oncology patients receiving moderate to highly emetogenic chemotherapy : a single-blinded, non-inferiority trial
This single-blinded, non-inferiority trial was conducted over an 8-month period to examine the efficacy of intravenous granisetron at two differing doses in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) among paediatric patients receiving moderate to highly emetogenic...
Main Authors: | Chong, Doris Sie Lau, Soh, Cheng Khai, Loh, C-Khai, Syed Zulkifli Syed Zakaria, Hamidah Alias |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2021
|
Online Access: | http://journalarticle.ukm.my/17535/1/17.pdf |
Similar Items
-
Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
by: Der Sheng Sun, et al.
Published: (2023-05-01) -
Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy
by: Rohan Bansal, et al.
Published: (2023-09-01) -
The effect and safety of olanzapine on nausea and vomiting in children receiving moderately emetogenic chemotherapy
by: Aziz Eghbali, et al.
Published: (2023-01-01) -
Combination of granisetron-dexamethasone in the prophylaxis of postoperative nausea and vomiting after thyroidectomy : Comparison with granisetron alone
by: A Rudra, et al.
Published: (2005-01-01) -
Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial
by: Aziz Eghbali, et al.
Published: (2023-07-01)